Movano Health (Nasdaq: MOVE), a California medical device company, has created a smart wearable specifically for women that is intended to provide them with accurate information about their overall well-being.
On Wednesday, the company announced the debut of the Evie smart ring, a device that translates medical data into personalized insights provided through a mobile application that doesn’t require a monthly subscription.
The company plans to seek FDA clearance for the smart ring, and upon approval Movano says Evie will become the first consumer wearable that is also a designated medical device. Evie will cost approximately US$300 and will be making its official debut at the CES (Consumer Electronics Show) 2023 in Las Vegas this coming January. It will become available for purchase mid-way through next year.
Movano says the rings are constructed in a medical device manufacturing facility that adheres to cGMP standards. The company also says the device will provide clinicians with reliable data for patient care.
Evie utilizes a combination of health and wellness metrics to provide women with a comprehensive picture of their overall health including sleep duration and stages, mood tracking, heart rate measurements, rate of respiration, ovulation and menstrual symptom tracking and calories burned throughout the day.
Movano aims to provide easily understandable data through the mobile app on these female health statistics, enabling women to make appropriate lifestyle changes and mitigate the risk of any long-term health issues from poor health habits.
“As a medical device, Evie will go beyond the status quo of other wearables on the market, and we believe it has the power to transform women’s lives and overall health,” said John Mastrototaro, CEO of Movano.
“We are bringing together medical-grade biometric data and insights in a comfortable and contemporary wearable that allows women to take ownership of their unique health journey.”